TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04253990

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Precut EMR
Description: For treating of 10\~20mm colon polyp, patient will be randomly divided into two groups, a Precut-EMR group and a EMR group.~In Precut-EMR, endoscopist submucosally inject with saline around a polyp. Subsequently, circumferential incision/precutting was made with the tip of the snare around 2 mm outside the tumor. After that, the snare was positioned in the cut groove and tightend, and the tumor was resected using electrical current.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional MER
Description: EMR had been widely used technique. Endoscopist submucosally inject with saline around a polyp. After that, snare is positioned around a polyp, and polyp was resected using electrical current.
Study: NCT02256267

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2835219
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2835219
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampin
Description: Administered orally
Study: NCT02109523

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI
Description: Five weekly motivational and volitional session sessions and each last about 50 minutes. Five registered psychologists will moderated the session. All MI technique and planing intervention will be used.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: volitional intervention
Description: Five weekly motivational and volitional session sessions and each last about 50 minutes. Five registered psychologists will moderated the session. All MI technique and planing intervention will be used.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Routine discharge counseling
Study: NCT03359057

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ethinyl estradiol + levonorgestrel + folic acid
Description: One coated tablet of ethinyl estradiol + levonorgestrel + folic acid, 0.02 mg + 0.10 mg + 0.4 mg for 21 days in 3 cycles (12 weeks).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Folic Acid
Description: One coated tablet of folic acid 0.4 mg for 7 days in 3 cycles (12 weeks).
Study: NCT01282190

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational interview
Description: Motivational interview
Study: NCT04576390

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron 4 mg
Description: Antiemetic drug

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Palonosetron 75 mcg
Description: Antiemetic drug
Study: NCT02276690

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: hepcidin
Description: In order to assess iron deficiency by innovative method (dosage of Hepcidin), an additional collection of blood will be done at day 0 (and weekly until Intensive Care Unit discharge) and at Day 15 after Intensive Care Unit discharge.~Treatement of Iron deficiency anaemia and anaemia of chronic disease using intravenous iron (± erythropoietin) will be encouraged (or not) according to hepcidin levels

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ferritin and transferrin saturation
Description: In order to assess iron deficiency by using usual biomarkers (ferritin and transferrin saturation), collection of blood will be done at day 0 (and weekly until Intensive Care Unit discharge) and at Day 15 after Intensive Care Unit discharge.~Treatement of Iron deficiency anaemia and anaemia of chronic disease using intravenous iron (± erythropoietin) will be encouraged (or not) according to ferritin levels.
Study: NCT00935701

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupressure and Acupuncture
Description: Acupressure involves the stimulation of specific acupoints by firm pressure, while acupuncture involves the insertion of very fine needles (the size of a strand of hair). The needles may be quickly inserted and removed or left in up to 5 minutes at a time.
Study: NCT04521998

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroacupuncture
Description: Electroacupuncture used to reduce the inflammation was proved previously.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS
Description: Patients who unlike needles would like to choose TENS as treatment for pain relief.
Study: NCT04294316

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Sonovue
Description: Twice dose of 2.4ml of Sulphur hexafluoride microbubbles contrast Sonovue administration to evaluate brain microcirculation
Study: NCT01239888

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: 20 IU of intranasal oxytocin twice per day for 8 weeks, and a placebo (oral) for the 8 week trial

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin and Tibolone
Description: 20 IU of intranasal oxytocin twice per day for 8 weeks, and 2.5mg oral tibolone for the 8 week trial

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 20 IU of intranasal placebo twice per day for 8 weeks, and a placebo (oral) for the 8 week trial
Study: NCT01892761

Intervention type: DRUG
Intervention: Renal transplant recipients were allocated to TCL/MMF or to CyA/MMF groups

Intervention type: DRUG
Intervention: Renal transplant recipients were allocated to TCL/MMF or to CyA/MMF groups
Study: NCT03003078

Intervention type: DEVICE
Group type: OTHER
Intervention: OncoSil™
Description: The implantation of OncoSil™
Study: NCT00266838

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Maxidex; Lacrystat
Description: 6 times daily, for 20 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Maxidex; Lacrystat
Description: 6 times daily, for 20 weeks.
Study: NCT01269424

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: MGMTP140K-encoding retroviral vector

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: O6-benzylguanine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: O6-benzylguanine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: O6-benzylguanine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: temozolomide
Study: NCT05172453

Intervention type: OTHER
Intervention: comprehensive management algorithm for preventing mother-to-child transmission of HBV
Description: To standardize the clinical management of preventing MTCT of HBV and reduce incidences of MTCT, the Chinese Foundation for Hepatitis Prevention and Control (CFHPC) organized experts to compile the Management algorithm for prevention of mother-to-child transmission of hepatitis B virus based on the latest research progress and recently published guidelines, which includes 10 steps of pregnancy management and postpartum follow-up, among which screening, antiviral treatment, and infant immunization are its core contents.

Intervention type: OTHER
Intervention: comprehensive management algorithm for preventing mother-to-child transmission of HBV
Description: To standardize the clinical management of preventing MTCT of HBV and reduce incidences of MTCT, the Chinese Foundation for Hepatitis Prevention and Control (CFHPC) organized experts to compile the Management algorithm for prevention of mother-to-child transmission of hepatitis B virus based on the latest research progress and recently published guidelines, which includes 10 steps of pregnancy management and postpartum follow-up, among which screening, antiviral treatment, and infant immunization are its core contents.
Study: NCT00894218

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroplasty
Description: Hip or knee arthroplasty

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroplasty
Description: Hip or knee arthroplasty
Study: NCT01269424

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: temozolomide

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: temozolomide

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: laboratory biomarker analysis

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: laboratory biomarker analysis
Study: NCT03037099

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced GI Concept Education
Study: NCT03504813

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activities program
Description: To implement this line, the protocol of the VIVIFRAIL Project will be used as a reference. That protocol has different physical exercises, divided into itineraries, in order to adapt it to a person's capability. Several sessions of this research line will employ the use of videogames so that the elderly can explore new forms of physical activity and thus establish contact and expertise with new technologies. It is estimated that two sessions per week over two months are needed for each person to continue doing physical activity independently and with autonomy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activities program
Description: To implement this line, the protocol of the VIVIFRAIL Project will be used as a reference. That protocol has different physical exercises, divided into itineraries, in order to adapt it to a person's capability. Several sessions of this research line will employ the use of videogames so that the elderly can explore new forms of physical activity and thus establish contact and expertise with new technologies. It is estimated that two sessions per week over two months are needed for each person to continue doing physical activity independently and with autonomy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activities program
Description: To implement this line, the protocol of the VIVIFRAIL Project will be used as a reference. That protocol has different physical exercises, divided into itineraries, in order to adapt it to a person's capability. Several sessions of this research line will employ the use of videogames so that the elderly can explore new forms of physical activity and thus establish contact and expertise with new technologies. It is estimated that two sessions per week over two months are needed for each person to continue doing physical activity independently and with autonomy.
Study: NCT01269424

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: laboratory biomarker analysis

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: autologous hematopoietic stem cell transplantation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: autologous hematopoietic stem cell transplantation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: autologous hematopoietic stem cell transplantation
Study: NCT03504813

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Relaxation training
Description: Will take place with those participants who are included in the research lines of insomnia and risk of falls. It is estimated that two sessions per week for one month are needed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training of the pelvic floor
Description: the intervention will apply to participants enrolled in the research line dealing with urinary incontinence during the six months of intervention, with a frequency of two sessions per week

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling about occupational performance
Description: After the physical activity and relaxation programs, the counselling will start. With each participant, routines and daily activities will be planned that will be adequate according to different recommendations about urinary incontinence, insomnia and risk of falls. Different performance guidelines will be established in order to establish a good balance between activities. The guidelines can include the recommendations about adjustments to the environment. It is estimated that three sessions per week for two months are needed to incorporate advice and routines into the daily lives of participants.
Study: NCT01269424

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: in vitro-treated peripheral blood stem cell transplantation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: in vitro-treated peripheral blood stem cell transplantation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: in vitro-treated peripheral blood stem cell transplantation

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiation therapy

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiation therapy

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiation therapy
Study: NCT01361464

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tipifarnib
Description: Given PO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study: NCT01537029

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: Dosed by the patient's treating physician according to local standard of care.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: dosage form: IV, Dosage, frequency, and duration: According to local standard of care
Study: NCT04837157

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exoskeleton rehabilitation
Description: The participants will perform physical therapy with the ATLSA2030 device, for 90 minutes per session.
Study: NCT02511366

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ileal infusion of casein
Description: Intraileal infusion of casein

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Ileal infusion of tap water
Description: Intraileal infusion of tap water
Study: NCT03504813

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling about occupational performance
Description: After the physical activity and relaxation programs, the counselling will start. With each participant, routines and daily activities will be planned that will be adequate according to different recommendations about urinary incontinence, insomnia and risk of falls. Different performance guidelines will be established in order to establish a good balance between activities. The guidelines can include the recommendations about adjustments to the environment. It is estimated that three sessions per week for two months are needed to incorporate advice and routines into the daily lives of participants.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling about occupational performance
Description: After the physical activity and relaxation programs, the counselling will start. With each participant, routines and daily activities will be planned that will be adequate according to different recommendations about urinary incontinence, insomnia and risk of falls. Different performance guidelines will be established in order to establish a good balance between activities. The guidelines can include the recommendations about adjustments to the environment. It is estimated that three sessions per week for two months are needed to incorporate advice and routines into the daily lives of participants.
Study: NCT01344161

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: dosage form:lactose dosage: 25 micrograms frequency: every day duration: 12weeks
Study: NCT00586833

Intervention type: PROCEDURE
Intervention: O2 consumption max bike test
Description: Single visit exercise study

Intervention type: PROCEDURE
Intervention: O2 consumption max bike test
Description: Single visit exercise study

Intervention type: PROCEDURE
Intervention: O2 consumption max bike test
Description: Single visit exercise study
Study: NCT02220023

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INOmax Inhalation
Study: NCT01544452

Intervention type: PROCEDURE
Group type: OTHER
Intervention: MR colonography and MR of the liver
Description: Altered planned surgical procedure if MR colonoscopy reveals synchronous cancer or larger polyps

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Standard diagnostic evaluation
Description: Altered planned surgical procedure if MR colonoscopy reveals synchronous cancer or larger polyps
Study: NCT02249494

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: telehealth
Description: Use the call service offered by the Center for Telehealth Rio Grande do Sul to answer clinic questions with qualified staff and in real time. All physicians who work in Primary Health Care in Brazil can call when they have questions about diagnosis and management of their patients.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: telehealth
Description: Use the call service offered by the Center for Telehealth Rio Grande do Sul to answer clinic questions with qualified staff and in real time. All physicians who work in Primary Health Care in Brazil can call when they have questions about diagnosis and management of their patients.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nutritional counseling
Description: Performing routine nutritional counseling in their clinical practice
Study: NCT02018549

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inhalation through Chiesi NEXThaler DPI
Description: Inhalatory manoeuvre through Chiesi NEXThaler DPI repeated at least twice in order to have two evaluable data set
Study: NCT03032198

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Imagio OA/US
Description: Diagnostic opto-acoustic gray-scale ultrasound
Study: NCT00746759

Intervention type: DEVICE
Intervention: Biomarker (not used as an intervention)
Description: This study is an observational study. There is no intervention.
Study: NCT01885559

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lisinopril
Description: Lisinopril titrated to 5mg, 10mg, 20mg, 40mg as tolerated by participants, to achieve standard blood pressure control of 110-130/80 mm Hg.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lisinopril
Description: Lisinopril titrated to 5mg, 10mg, 20mg, 40mg as tolerated by participants, to achieve standard blood pressure control of 110-130/80 mm Hg.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Telmisartan
Description: Telmisartan titrated to 40mg and 80mg, as tolerated by participants, to achieve standard blood pressure control of 110-130/80 mm Hg.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo titrated to 40mg and 80mg, as tolerated by participants, to achieve standard blood pressure control of 110-130/80 mm Hg.
Study: NCT02249494

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: nutritional counseling
Description: Performing routine nutritional counseling in their clinical practice

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: smartphone (mobile app)
Description: Mobile app, designed to provide nutritional recommendations for hypertensive patients, will be use. The recommendations will be based on the DASH diet guidelines appropriate to the patient profile: consumption of whole grains, fruits, vegetables, milk or low fat dairy products, lean meats, poultry and fish, nuts, seeds and legumes, amount of fats, oils and sweets, as well as guidelines for salt intake and alcohol.
Study: NCT02046304

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Starting dose: 400 mg/m2 by vein on days 1, 8, 22, 29, 43, and 50.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Radiation therapy dose of 50 Gy in 25 fractions at 2.0 Gy per fraction. Radiotherapy given once daily (Monday through Friday) for 5 weeks.
Study: NCT02318810

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium 0.3 mg/kg
Description: Patients receive rocuronium 0.3 mg/kg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium 0.6 mg/kg
Description: Patients receive rocuronium 0.6 mg/kg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium 0.9 mg/kg
Description: Patients receive rocuronium 0.9 mg/kg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients receive saline
Study: NCT03102892

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Scaling root planing
Description: Treatment by scaling and root planing alone.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scaling root planing
Description: Treatment by scaling and root planing alone.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy
Description: Treatment with methylene blue dye and red laser
Study: NCT03650166

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MyBP
Description: This program includes online video high BP education and longitudinal, personalized assistance of home BP self-monitoring.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Personal BP monitor
Description: Battery-powered BP monitor for personal use

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personal BP monitor
Description: Battery-powered BP monitor for personal use
Study: NCT03247595

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Magnesium Citrate Capsules
Description: 36 magnesium citrate gelatin capsules

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene Glycol 3350
Description: 4 liters of Polyethylene Glycol for colonoscopy preparation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dulcolax Tablets
Description: 4 Dulcolox Tablets
Study: NCT02892019

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indacaterol acetate 75 μg
Description: Indacaterol acetate 75 μg o.d. delivered via Concept1 inhaler

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indacaterol acetate 150 μg
Description: Indacaterol acetate 150 μg o.d. delivered via Concept1 inhaler
Study: NCT01667198

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Train the leaders course
Description: Screening centre leaders randomized to the training intervention group will be invited to take part in a train-the-leaders course. The Train-the-leaders course will consist of three phases: (i) pre-training assessment, (ii) hands-on-training and (iii) post-training evaluation and feedback. The Train-the-leaders course will be run in polish by the team from the Maria Sklodowska-Curie Memorial Cancer Center and Institute on Oncology, Warsaw, which was trained in delivering such intervention by experts from the United Kingdom.
Study: NCT02352636

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: magnetotherapy
Description: The magnetic pellets will contain an average of \~200 gauss/pellet magnetic flux densities, with a diameter of 1.76 mm